Namesh kamat retweeted
Why are freshly passed DM/MCh doctors in India often not allowed to practice independently in corporate hospitals?
Why the mandatory “2 years as Associate Consultant” in so many centres?
A freshly qualified DM doctor has already completed years of MBBS + MD + 3 years of super-speciality training. Yet, after completing the highest formal qualification in the field, they are sometimes expected to spend another 2 years doing the hard clinical work of a consultant—while having limited independent OPD/IPD privileges, recognition and decision-making autonomy.
Is this genuinely about patient safety and mentorship?
Or has “Associate Consultant” quietly become an extension of residency?
If structured mentorship is needed, absolutely. But it should have clear objectives, timelines, competencies and fair recognition.
We need to ask: Are we training super-specialists, or creating a prolonged hierarchy where independent practice is delayed simply because the system allows it?
#MedX #MedTwitter
#DMDoctors #MCh #MedicalEducation #Healthcare #DoctorsOfIndia #GSR
Namesh kamat retweeted
Lower Time Averaged-Proteinuria (TA-P) was associated with progressively reduced risk of kidney failure in adults with IgA Nephropathy #IgAN in the US ca. 2026 from @GlomCon Rare Kidney Disease Journal
#Nephpearls
📌 This underscores the importance of achieving and maintaining proteinuria levels below the threshold of 0.5 g/day and ideally < 0.3 g/day to delay kidney failure, consistent with @goKDIGO recommended treatment goals
👉 link.springer.com/article/10… – at Riverside, IL
Namesh kamat retweeted
💪 Building muscle is great.
But not at the cost of your kidneys. 🫘
“Gym nephropathy” refers to kidney injury linked to: ⚠️ Overtraining
⚠️ Dehydration
⚠️ Steroid use
⚠️ Unsafe supplements
⚠️ Excess painkiller use
Warning signs:
🚨 Dark urine
🚨 Severe muscle pain
🚨 Vomiting or extreme weakness
🚨 Reduced urine output
Protein supplements and creatine are not always harmless — especially with dehydration, excessive use, or pre-existing kidney disease.
Real fitness means:
✅ Strong body
✅ Healthy kidneys
✅ Smart training habits
Stay hydrated.
Avoid steroids and unregulated supplements.
Train smart, not reckless. 👊
#GSR #BuddingNephros #Gym #Muscle #Fitness
Namesh kamat retweeted
AKI in rhabdomyolysis is a medical emergency that can rapidly progress without timely intervention.
🔹 Key mechanisms: • Myoglobin-induced tubular toxicity
• Tubular obstruction by casts
• Renal vasoconstriction & ischemia
🔹 Important clues: • Muscle pain & weakness
• Dark “tea-colored” urine
• Markedly elevated CK
• Hyperkalemia & rising creatinine
🔹 Management pearls: ✅ Early aggressive IV fluids
✅ Avoid nephrotoxins
✅ Monitor electrolytes closely
✅ Consider urine alkalinization in selected cases
✅ Dialysis when indicated
Early recognition + aggressive hydration can prevent severe AKI and improve outcomes.
#GSR #BuddingNephros
#Nephrology #AKI #Rhabdomyolysis #KidneyDisease #CriticalCare
Namesh kamat retweeted
Congenital & childhood nephrotic syndrome is increasingly recognized as a genetic podocytopathy.
Key genes include:
🔹 NPHS1 – Finnish congenital NS
🔹 WT1 – Denys-Drash / Frasier syndrome
🔹 LAMB2 – Pierson syndrome
🔹 NPHS2, PLCE1, INF2, TRPC6 – SRNS/FSGS
🔹 COQ2/COQ6/COQ8B – potentially treatable CoQ10 pathway defects
🚩 Suspect genetic NS when:
✔️ Onset <1 year
✔️ Steroid resistance
✔️ Family history/consanguinity
✔️ Syndromic or extrarenal features
🧪 Early genetic testing helps avoid unnecessary immunosuppression and enables targeted therapy & counseling.
#GSR #BuddingNephros #NephroticSyndrome
Namesh kamat retweeted
🩺 Podocyte-protecting drugs are changing modern nephrology practice.
Podocyte injury is a key driver of proteinuria and CKD progression. Important podocyte-protective therapies include:
✅ RAAS blockers (ACEi/ARBs)
✅ SGLT2 inhibitors
✅ Finerenone & other MRAs
✅ Calcineurin inhibitors
✅ Endothelin pathway inhibitors
✅ Rituximab in selected glomerular diseases
🎯 Goals:
• Reduce proteinuria
• Preserve glomerular filtration barrier
• Slow CKD progression
• Improve long-term renal outcomes
The strongest evidence today supports:
🛡️ RAAS blockade + SGLT2 inhibitor ± Finerenone
#GSR #BuddingNephros
#Nephrology #Proteinuria #KidneyDisease #GlomerularDisease #MedTwitter
Namesh kamat retweeted
Membranous nephropathy is no longer just “primary vs secondary” disease — it is now an ANTIGEN-SPECIFIC podocytopathy.
🔬 Newer antigens are redefining diagnosis & prognosis:
▪️ NELL1 → malignancy/drug-associated MN
▪️ EXT1/EXT2 & NCAM1 → lupus/autoimmune MN
▪️ SEMA3B → pediatric MN
▪️ FAT1 → post-HSCT MN
▪️ CNTN1 → neuropathy-associated MN
▪️ PCDH7 → indolent MN phenotype
⚡ Emerging concept: Dual-antigen MN
(NELL1+PLA2R, NCAM1+EXT1/2 etc.) suggesting complex autoimmune evolution.
🧪 Mass spectrometry-based antigen mapping is becoming the future gold standard for PLA2R-negative MN.
#GSR #BuddingNephros #MembranousNephropathy #RenalPathology #NephTwitter #MedTwitter
Namesh kamat retweeted
🩸 Kidneys do much more than filter toxins — they also produce erythropoietin (EPO), the hormone responsible for red blood cell production.
In Chronic Kidney Disease, reduced EPO production leads to anemia, causing: ▪️ Fatigue
▪️ Breathlessness
▪️ Weakness
▪️ Poor exercise tolerance
Management includes:
✔️ Iron optimization
✔️ ESA therapy
✔️ Newer HIF-PH inhibitors
Correcting anemia in CKD improves quality of life and reduces transfusion needs — but overcorrection may increase cardiovascular risk.
#GSR #BuddingNephros
#CKD #Nephrology #Anemia #Erythropoietin #MedTwitter #NephTwitter
Namesh kamat retweeted
🚰 Hemodialysis is no longer just about diffusion.
💡 The future is convective.
#Hemodiafiltration (#HDF) combines diffusion + convection to achieve superior clearance of middle molecules and protein-bound toxins.
📚 Trials like
• ESHOL Trial
• CONTRAST Trial
• CONVINCE Trial
suggest better survival and cardiovascular outcomes with high-volume HDF.
🎯 Target convection volume:
➡️ ≥ 23 L/session
Why nephrologists are increasingly embracing HDF:
✅ Better middle molecule clearance
✅ Improved hemodynamic tolerance
✅ Better phosphate control
✅ Reduced inflammation
✅ Potential survival benefit
“More than filtration.
It’s better purification.
It’s better care.”
#GSR #BuddingNephros
#Nephrology #Dialysis #KidneyDisease #CKD #NephTwitter #MedTwitter #HDF
Namesh kamat retweeted
😖Often, females with advanced renal failure (CKD stage 4–5) and recurrent UTIs are among the most difficult patients to manage.
🧩Balancing infection control, nephrotoxicity, antimicrobial resistance, dialysis status, and electrolyte disturbances is challenging.
🔍Key points:
• Confirm true recurrent UTI (not asymptomatic bacteriuria)
• Vaginal estrogen is highly useful in postmenopausal women
• Avoid unnecessary broad-spectrum antibiotics
• Nitrofurantoin should usually be avoided if eGFR <30
• Low-dose cephalexin or intermittent fosfomycin may help selected patients
• Always individualize therapy based on cultures and renal function
What has worked best in your practice for recurrent UTI prophylaxis in CKD stage 4–5 patients?
#GSR #BuddingNephros #Nephrology #CKD #UTI #Urology
Namesh kamat retweeted
🧵 Transplant Renal Artery Stenosis (TRAS)
A reversible cause of graft dysfunction & resistant HTN in renal transplant patients👇
1️⃣ What happens?
Renal artery narrowing → ↓ perfusion → RAAS activation → HTN + fluid retention + graft dysfunction
2️⃣ When to suspect?
📍 3–24 months post-transplant
📍 Resistant HTN
📍 Rising creatinine
📍 Flash pulmonary edema
3️⃣ Key Doppler findings
🔹 PSV >200–250 cm/s
🔹 Tardus–Parvus waveform
4️⃣ Role of Resistive Index (RI)
👉 Low RI (<0.5–0.6) = suggests TRAS
👉 High RI (>0.7) = parenchymal disease
✅ TRAS = LOW RI + Tardus–Parvus
5️⃣ Diagnosis
🔍 Doppler = screening
🔍 CTA / MRA = confirm
🏆 Angiography = gold standard
6️⃣ Treatment
💊 Medical (temporary)
🎯 Angioplasty ± stenting = first-line
#GSR #BuddingNephros #Transplant #Kidney
Namesh kamat retweeted
🧠 Mycophenolate (MMF/MPS) in Renal Transplant
🔬 MOA: Inhibits IMPDH → ↓ T & B cell proliferation → ↓ rejection
💊 Dose:
MMF: 1–1.5 g BD
MPS: 720 mg BD (≈ MMF 1 g BD)
⚠️ When to reduce:
• Leukopenia / Neutropenia
• Severe diarrhea
• CMV / BK / sepsis
• Malignancy
🚫 No renal dose adjustment
📉 First drug to reduce in infection = Mycophenolate
#GSR #BuddingNephros #Transplant #Mycophenolate #NephX














